English
This article is from Indian Journal of Pharmacology , volume 44 . Abstract Objectives:: Setarud (IMOD™) is a herbal medicine with beneficial effect for patients suffering Human immunodeficiency virus (HIV) infection and has been approved for IV (intra venues) injection. The beneficial effect of IMOD administration for acquired immune deficiency syndrome (AIDS) patient has been proved in previous clinical trials. Here the in vitro inhibitory effect of IMOD against HIV-1, Herpes simplex virus (HSV) and murine leukemia viruses (MLV) was evaluated. Materials and Methods:: HIV single cycle replication and HSV plaque reduction assays were used to evaluate the anti-viral effect. The level of HIV replication was monitored by p24 capture Enzyme-linked immunosorbent assay (ELISA). The single round infection [with green fluorescent protein (GFP) reporter MLV and HIV], virucidal and time-of-additions (HSV) assays were utilized to determine the mode of anti-viral activity. The toxicity of IMOD for cells was monitored by XTT (sodium 3_-[1 (phenylaminocarbonyl)- 3,4-tetrazolium]-bis (4-methoxy-6-nitro)benzene sulfonic acid) cell proliferation assay kit. Results:: IMOD inhibited 50% of HIV-1 and H
Sign in with your free account to read, download EPUBs or listen.
Ebook · The in vitro anti-viral potential of Setarud (IMOD(TM)), a commercial herbal medicine with protective activity against acquired immune deficiency syndrome in clinical trials. · Zabihollahi, Rezvan, Namazi, Rahele, Aghasadeghi, Mohammad Reze, Esfahani, Azar Farhang, Sadat, Seyed Mehdi, Modarressi, Mohammad Hossein · Internet Archive